Issue 2/2007
Content (13 Articles)
Analysis of naïve and memory CD4 and CD8 T cell populations in breast cancer patients receiving a HER2/neu peptide (E75) and GM-CSF vaccine
Matthew T. Hueman, Alexander Stojadinovic, Catherine E. Storrer, Zia A. Dehqanzada, Jennifer M. Gurney, Craig D. Shriver, Sathibalan Ponniah, George E. Peoples
Endowing self-binding feature restores the activities of a loss-of-function chimerized anti-GM2 antibody
Yunfeng Zhao, Michael Russ, Marc Retter, Gary Fanger, Charles Morgan, Heinz Kohler, Sybille Muller
In vivo tracking of macrophage activated killer cells to sites of metastatic ovarian carcinoma
D. Ritchie, L. Mileshkin, D. Wall, J. Bartholeyns, M. Thompson, J. Coverdale, E. Lau, J. Wong, P. Eu, R. J. Hicks, H. M. Prince
Immunotherapy success in prophylaxis cannot predict therapy: prime-boost vaccination against the 5T4 oncofoetal antigen
Sumia Ali, Kate Mulryan, Taher Taher, Peter L. Stern
Induction of an effective anti-tumor immune response and tumor regression by combined administration of IL-18 and Apoptin
Hai Lian, Ningyi Jin, Xiao Li, Zhiqiang Mi, Jingmin Zhang, Lili Sun, Xuemei Li, Hongling Zheng, Ping Li
Retinoic acid elicits cytostatic, cytotoxic and immunomodulatory effects on uveal melanoma cells
Simona Vertuani, Eugenia Dubrovska, Victor Levitsky, Martine J. Jager, Rolf Kiessling, Jelena Levitskaya
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10
Mingzhong Zheng, Dora Bocangel, Blair Doneske, Abner Mhashilkar, Rajagopal Ramesh, Kelly K. Hunt, Suhendan Ekmekcioglu, R. Bryan Sutton, Nancy Poindexter, Elizabeth A. Grimm, Sunil Chada
Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice
Arthur Machlenkin, Ronit Azriel-Rosenfeld, Ilan Volovitz, Ezra Vadai, Avital Lev, Adrian Paz, Ofir Goldberger, Yoram Reiter, Esther Tzehoval, Itai Benhar, Lea Eisenbach
Immune selective pressure and HLA class I antigen defects in malignant lesions
Chien-Chung Chang, Soldano Ferrone
Low-dose cyclophosphamide modulates galectin-1 expression and function in an experimental rat lymphoma model
Mariano F. Zacarías Fluck, María J. Rico, Silvia I. Gervasoni, Juan M. Ilarregui, Marta A. Toscano, Gabriel A. Rabinovich, O. Graciela Scharovsky
Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients
Alfred Zippelius, Asma Gati, Tammo Bartnick, Senta Walton, Bernhard Odermatt, Elke Jaeger, Reinhold Dummer, Mirjana Urosevic, Valeriy Filonenko, Kazuhiro Osanai, Holger Moch, Yao-Tseng Chen, Lloyd J. Old, Alexander Knuth, Dirk Jaeger
Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195–203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules
Tomoko So, Takeshi Hanagiri, Jacques Chapiro, Didier Colau, Francis Brasseur, Kosei Yasumoto, Thierry Boon, Pierre G. Coulie